OncBioMune Pharmaceuticals, Inc Purchase Agreements
24 Contracts & Agreements
- Form of Securities Purchase Agreement (Filed With SEC on December 1, 2022)
- Form of Securities Purchase Agreement for April 2022 (Filed With SEC on May 23, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on February 3, 2022)
- Securities Purchase Agreement, dated November 1, 2021 (Filed With SEC on November 5, 2021)
- Securities Purchase Agreement, dated July 30, 2021 (Filed With SEC on August 6, 2021)
- Securities Purchase Agreement, dated May 12, 2021 (Filed With SEC on May 19, 2021)
- Securities Purchase Agreement, dated September 16, 2020, by and among OncBioMune Pharmaceuticals, Inc. and the Investor (Filed With SEC on September 22, 2020)
- Securities Purchase Agreement, dated June 5, 2020, by and among OncBioMune Pharmaceuticals, Inc. Cavalry Fund I LP and Lincoln Park Capital Fund, LLC (Filed With SEC on June 11, 2020)
- Asset Purchase Agreement, dated May 12, 2020, between OncBioMune Pharmaceuticals, Inc. and Avant Diagnostics, Inc (Filed With SEC on May 13, 2020)
- Securities Purchase Agreement dated September 25, 2019 (Filed With SEC on November 19, 2019)
- Securities Purchase Agreement (Filed With SEC on August 6, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on July 18, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on May 2, 2019)
- Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Cavalry Fund I LP, dated March 25, 2019 (Filed With SEC on April 1, 2019)
- Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and Cerberus Finance Group Ltd (Filed With SEC on February 4, 2019)
- Securities Purchase Agreement, dated as of January 18, 2019, by and between OncBioMune Pharmaceuticals, Inc. and LG Capital Funding LLC (Filed With SEC on January 29, 2019)
- Securities Purchase Agreement between Cavalry I LP and OncBioMune, Inc., dated November 13, 2018 (Filed With SEC on November 14, 2018)
- Securities Purchase Agreement, dated September 24, 2018 (Filed With SEC on November 14, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on July 31, 2018)
- Form of Securities Purchase Agreement dated March 13, 2018 (Filed With SEC on May 31, 2018)
- Form of Securities Purchase Agreement dated January 29, 2018 (Filed With SEC on May 31, 2018)
- Web Site Asset Purchase Agreement dated May 17, 2013 between Lakefield Media Holding AG, Flawsome XLerator GmBH and Pediatrix Inc (Filed With SEC on June 28, 2013)
- Asset Purchase Agreement dated February 21, 2012 with Apricus Biosciences, Inc (Filed With SEC on May 18, 2012)
- Asset Purchase Agreement dated July 22, 2010 with Cypress Pharmaceuticals, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment) (Filed With SEC on July 28, 2010)